Tectonic Therapeutic Inc (TECX) FinancialsTECXTectonic Therapeutic Inc

Evaluating the bottom line, Tectonic Therapeutic, Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -33.80%, provide a clear picture of how effectively TECX converts its operational activities into shareholder value.

In the context of the broader market, TECX competes directly with industry leaders such as PRAA and CASS. With a market capitalization of $682.47M, it holds a significant position in the sector. When comparing efficiency, TECX's gross margin of N/A stands against PRAA's N/A and CASS's 92.56%. Such benchmarking helps identify whether Tectonic Therapeutic, Inc. is trading at a premium or discount relative to its financial performance.

Despite negative net income figures, Tectonic has a strong current ratio of 22.29, indicating good short-term liquidity. The company has seen a remarkable year-to-date change of +70.35% and a one-year change of +113.93%, reflecting strong market interest and potential.